{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:01:29Z","timestamp":1793898089624,"version":"4.8.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.redox.2025.103499","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:44:58Z","timestamp":1737564298000},"page":"103499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9"],"prefix":"10.1016","volume":"80","author":[{"given":"Xin","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-1636","authenticated-orcid":false,"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.redox.2025.103499_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.redox.2025.103499_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.redox.2025.103499_bib5","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.redox.2025.103499_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MASLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"issue":"8","key":"10.1016\/j.redox.2025.103499_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MASLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.redox.2025.103499_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.redox.2025.103499_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1301335","article-title":"Sugar sweetened beverages, natural fruit juices, and cancer: what we know and what still needs to be assessed","volume":"10","author":"Eshaghian","year":"2023","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.redox.2025.103499_bib10","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.clnu.2021.04.011","article-title":"Beverages and Non-alcoholic fatty liver disease (NAFLD): think before you drink","volume":"40","author":"Chhimwal","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2014.10.005","article-title":"Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort","volume":"148","author":"Setiawan","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.redox.2025.103499_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.24731","article-title":"Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis","volume":"55","author":"Molloy","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc13-1203","article-title":"Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis","volume":"37","author":"Ding","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.diabet.2015.09.001","article-title":"Coffee consumption and risk of the metabolic syndrome: a meta-analysis","volume":"42","author":"Shang","year":"2016","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.redox.2025.103499_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.784354","article-title":"Caffeine and EGCG alleviate high-trans fatty acid and high-carbohydrate diet-induced NASH in mice: commonality and specificity","volume":"8","author":"Xin","year":"2021","journal-title":"Front. Nutr."},{"issue":"32","key":"10.1016\/j.redox.2025.103499_bib17","doi-asserted-by":"crossref","first-page":"30187","DOI":"10.1074\/jbc.M302010200","article-title":"Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance","volume":"278","author":"Xu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib18","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1073\/pnas.0712275105","article-title":"Overexpression of the dual-specificity phosphatase MKP-4\/DUSP-9 protects against stress-induced insulin resistance","volume":"105","author":"Emanuelli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.30198","article-title":"Dual-specificity phosphatase 9 protects against nonalcoholic fatty liver disease in mice through ASK1 suppression","volume":"69","author":"Ye","year":"2019","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.redox.2025.103499_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111538","article-title":"DUSP9, a dual-specificity phosphatase with a key role in cell biology and human diseases","volume":"22","author":"Khoubai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103499_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12986-020-00462-y","article-title":"High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis","volume":"17","author":"Xin","year":"2020","journal-title":"Nutr. Metab."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41575-022-00717-4","article-title":"NAFLD, MASLD and obesity: brothers in arms?","volume":"20","author":"Machado","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib23","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.redox.2025.103499_bib25","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.redox.2025.103499_bib26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/2211-5463.12240","article-title":"Silencing of FABP 1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease","volume":"7","author":"Mukai","year":"2017","journal-title":"FEBS open bio"},{"issue":"7394","key":"10.1016\/j.redox.2025.103499_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature10986","article-title":"A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism","volume":"484","author":"Herman","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/diabetes.49.6.969","article-title":"Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes","volume":"49","author":"Clore","year":"2000","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.redox.2025.103499_bib29","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180147","article-title":"Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression","volume":"8","author":"Sefried","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/j.redox.2025.103499_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep28786","article-title":"CXCL10-Mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis","volume":"6","author":"Tomita","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.redox.2025.103499_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/gut.2005.075697","article-title":"Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease","volume":"55","author":"Malaguarnera","year":"2006","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.redox.2025.103499_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10100784","article-title":"Liver biopsy hydroxyproline content is a diagnostic for hepatocellular carcinoma in murine models of nonalcoholic steatohepatitis","volume":"10","author":"Bissoondial","year":"2020","journal-title":"Diagnostics"},{"issue":"1 Pt A","key":"10.1016\/j.redox.2025.103499_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbamem.2013.04.028","article-title":"Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery","volume":"1838","author":"Patching","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2025.103499_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102963","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrgastro.2017.42","article-title":"NASH: novel therapeutic strategies targeting ASK1 in NASH","volume":"14","author":"Schuster","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib37","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2016.02.002","article-title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis","volume":"64","author":"Xiang","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.redox.2025.103499_bib39","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.redox.2025.103499_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2025.103499_bib41","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00394-018-1711-4","article-title":"Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"58","author":"Asgari-Taee","year":"2019","journal-title":"Eur. J. Nutr."},{"issue":"10","key":"10.1016\/j.redox.2025.103499_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tem.2014.07.003","article-title":"Impact of caffeine and coffee on our health","volume":"25","author":"de Mejia","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.redox.2025.103499_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2012.07.014","article-title":"Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery","volume":"57","author":"Anty","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1756283X15593700","article-title":"Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis","volume":"9","author":"Shen","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021703","article-title":"GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives","volume":"24","author":"Nevola","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.redox.2025.103499_bib46","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/oby.2005.142","article-title":"Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation","volume":"13","author":"Westerterp-Plantenga","year":"2005","journal-title":"Obes. Res."},{"issue":"9344","key":"10.1016\/j.redox.2025.103499_bib47","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0140-6736(02)11436-X","article-title":"Coffee consumption and risk of type 2 diabetes mellitus","volume":"360","author":"van Dam","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12937-021-00694-5","volume":"20","author":"Mansour","year":"2021","journal-title":"Nutr. J."},{"key":"10.1016\/j.redox.2025.103499_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1257969","article-title":"Beverage consumption in patients with metabolic syndrome and its association with non-alcoholic fatty liver disease: a cross-sectional study","volume":"11","author":"Kositamongkol","year":"2024","journal-title":"Front. Nutr."},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib50","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.clnu.2018.11.030","article-title":"A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease","volume":"38","author":"Chen","year":"2019","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib51","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1073\/pnas.0712275105","article-title":"Overexpression of the dual-specificity phosphatase MKP-4\/DUSP-9 protects against stress-induced insulin resistance","volume":"105","author":"Emanuelli","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.redox.2025.103499_bib52","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41423-021-00690-z","article-title":"The hepatic macrophage pool in NASH","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MEG.0b013e3283644e26","article-title":"Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-beta","volume":"26","author":"Arauz","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.intimp.2015.02.012","article-title":"Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP\/PKA\/CREB pathway in rat hepatic stellate cells","volume":"25","author":"Wang","year":"2015","journal-title":"Int. Immunopharm."},{"issue":"3","key":"10.1016\/j.redox.2025.103499_bib55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jgh.16087","article-title":"Mechanism of ASK1 involvement in liver diseases and related potential therapeutic targets: a critical pathway molecule worth investigating","volume":"38","author":"Chen","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.redox.2025.103499_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stem.2011.12.016","article-title":"BMP4 Signaling Acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells","volume":"10","author":"Li","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.redox.2025.103499_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2020.04.009","article-title":"Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1","volume":"153","author":"Wu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2025.103499_bib58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.30597","article-title":"Dual specificity phosphatase 12 regulates hepatic lipid metabolism through inhibition of the lipogenesis and apoptosis signal-regulating kinase 1 pathways","volume":"70","author":"Huang","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.redox.2025.103499_bib59","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.30485","article-title":"Dual-specificity phosphatase 26 protects against nonalcoholic fatty liver disease in mice through transforming growth factor beta-activated kinase 1 suppression","volume":"69","author":"Ye","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.redox.2025.103499_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1463-1326.2004.00389.x","article-title":"The appetite-suppressant effect of nicotine is enhanced by caffeine","volume":"7","author":"Jessen","year":"2005","journal-title":"Diabetes Obes. Metabol."},{"issue":"6","key":"10.1016\/j.redox.2025.103499_bib61","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/oby.20190","article-title":"Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight\/obese individuals","volume":"21","author":"Gavrieli","year":"2013","journal-title":"Obesity"},{"issue":"7","key":"10.1016\/j.redox.2025.103499_bib62","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1039\/D2FO02701A","article-title":"Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression via targeting EGFR","volume":"14","author":"Huang","year":"2023","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.redox.2025.103499_bib63","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.26667","article-title":"Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice","volume":"59","author":"Sinha","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.redox.2025.103499_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbalip.2018.12.003","article-title":"Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease","volume":"1864","author":"Fang","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"issue":"5","key":"10.1016\/j.redox.2025.103499_bib65","doi-asserted-by":"crossref","first-page":"G488","DOI":"10.1152\/ajpgi.00179.2022","article-title":"Coffee modulates insulin-hepatocyte nuclear factor-4alpha-Cyp7b1 pathway and reduces oxysterol-driven liver toxicity in a nonalcoholic fatty liver disease mouse model","volume":"323","author":"Kakiyama","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"17","key":"10.1016\/j.redox.2025.103499_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179954","article-title":"Caffeine inhibits NLRP3 inflammasome activation by downregulating TLR4\/MAPK\/NF-kappaB signaling pathway in an experimental NASH model","volume":"23","author":"Vargas-Pozada","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103499_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700483","article-title":"Potential biological effects of (-)-Epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease","volume":"62","author":"Chen","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"9","key":"10.1016\/j.redox.2025.103499_bib68","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/acschembio.9b00399","article-title":"CETSA beyond soluble targets: a broad application to multipass transmembrane proteins","volume":"14","author":"Kawatkar","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"W1","key":"10.1016\/j.redox.2025.103499_bib69","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T10:32:40Z","timestamp":1741948360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":69,"alternative-id":["S2213231725000126"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103499","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103499"}}